Learn More
Medchemexpress LLC Pantoprazole sodium hydrate | 164579-32-2 | 99.9% | 432.37 | 250 MG

Supplier: Medchemexpress LLC 250MGHY17507AR
Pantoprazole sodium hydrate is an orally active and potent proton pump inhibitor (PPI). It is a substituted benzimidazole and a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. It improves pH stability and has anti-secretory and anti-ulcer activities. When combined with Doxorubicin, Pantoprazole sodium hydrate significantly increased tumor growth delay.
- Potent proton pump inhibitor
- Improves pH stability
- Possesses anti-secretory activities
- Exhibits anti-ulcer activities
- Can increase tumor growth delay when combined with Doxorubicin
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.